Trial Profile
A Phase I Trial of STA-4783 in Patients Receiving Paclitaxel for Treatment of Solid Tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Dec 2009
Price :
$35
*
At a glance
- Drugs Elesclomol (Primary) ; Paclitaxel
- Indications Cancer
- Focus Adverse reactions
- Sponsors Synta Pharmaceuticals
- 29 Dec 2009 New trial record